Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870What this trial is testingTheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck CancersWho this might be right forHuman Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more University of Chicago 35
Early research (Phase 1)Study completedNCT03666273What this trial is testingPhase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.Who this might be right forAdvanced Solid TumorHead and Neck Squamous Cell Carcinoma Bayer 60
Testing effectiveness (Phase 2)UnknownNCT03585673What this trial is testingDocetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaWho this might be right forEsophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer Sung Yong Oh 38
Not applicableLooking for participantsNCT07088354What this trial is testingDeep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant ImmunochemotherapyWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more Tongji Hospital 300
Not applicableStudy completedNCT06244394What this trial is testingRetrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal CarcinomaRadiation-Induced Temporal Lobe Injury Jiangsu Cancer Institute & Hospital 230
Testing effectiveness (Phase 2)Active Not RecruitingNCT05659251What this trial is testingSerplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant Therapy Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Large-scale testing (Phase 3)Study completedNCT00002631What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the EsophagusWho this might be right forEsophageal Cancer Radiation Therapy Oncology Group 298
Early research (Phase 1)Ended earlyNCT03991741What this trial is testingAdoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid TumorsWho this might be right forMetastatic MelanomaLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more Gregory Daniels 3
Not applicableLooking for participantsNCT06443866What this trial is testingI-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid CancerWho this might be right forThyroid CancerRAI-Refractory Thyroid Cancer Miami Cancer Research Center, Inc. 50
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Not applicableLooking for participantsNCT06792786What this trial is testingProspective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA MonitoringWho this might be right forEsophageal CancerctDNA The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)Ended earlyNCT04844073What this trial is testingTAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerWho this might be right forSquamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer Takeda 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303283What this trial is testingBecotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal CarcinomaAdjuvant Therapy Kai Hu 140
Not applicableStudy completedNCT00875953What this trial is testingUse of the Harmonic Scalpel in Neck DissectionWho this might be right forNeck Dissection University of Calgary 34
Testing effectiveness (Phase 2)UnknownNCT04586088What this trial is testingApatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment FailureWho this might be right forNasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more Sun Yat-sen University 58
Testing effectiveness (Phase 2)Study completedNCT00948961What this trial is testingCDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Who this might be right forAdvanced Malignancies Celldex Therapeutics 70
Not applicableLooking for participantsNCT06979869What this trial is testingInvestigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal CarcinomaWho this might be right forEsophageal Cancer Xijing Hospital 300
Not applicableStudy completedNCT01392222What this trial is testingTreatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant OthersWho this might be right forThyroid CancerPapillary Microcarcinoma Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT02684253What this trial is testingScreening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)Who this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC) Memorial Sloan Kettering Cancer Center 65